|
Toronto Memory Program is now accepting applicants for the
new Pfizer-Alzheimer Society of Ontario Dementia Trial
Investigator Fellowship to commence 1 July 2013.
This one-year fellowship was created to address the need
for qualified investigators in the field of clinical
pharmacological research in dementia and will be of interest
to those who want to be involved in advancing treatment
options for this disease. The successful applicant will
acquire the knowledge and practical experience in dementia
research and dementia practice to act as Principal
Investigator at an independent trial site. The fellowship
takes place at Toronto Memory Program, Canada’s most active
dementia clinical pharmacological research site. Supervisor:
Dr. Sharon Cohen, PI and Behavioural Neurologist.
The fellowship curriculum involves hands on experience
with issues related to research practice as well as dementia
clinical practice, including but not limited to:
- Research regulations
- Principal Investigator responsibilities
- Study designs and protocol review
- Trial budgets and contracts
- Study start up activities
- Research visits; clinical trial operations
- Standard Operating Procedures
- Industry relations
- Audit preparation
- Clinical and research diagnostic criteria
- Standard of care in dementia treatment
|